SAGE Therapeutics, Inc. (NASDAQ:SAGE)

About the company

SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

675

CEO

Jeffrey M. Jonas

Exchange

NASDAQ

Website

http://www.sagerx.com

$9.00M

Total Revenue

675

Employees

$2B

Market Capitalization

-3.45

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$8M

Operating Margin (in %)

Total operating margin

$-39M

Net Margin (in %)

Total net margin

$-37M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 12018.30 1376.00 5.12 18.95 43.06
Catalent, Inc. CTLT 11623.49 2872.00 5.84 111.44 3.63
Perrigo Co. Plc PRGO 7607.61 4837.00 1.30 51.90 3.02
Jazz Pharmaceuticals Plc JAZZ 6076.20 2188.00 2.10 22.21 12.81
Bausch Health Cos., Inc. BHC 6068.07 8597.00 8.47 -3.21 -21.96
United Therapeutics Corp. UTHR 4985.85 1443.00 1.73 9.62 36.59
MyoKardia, Inc. MYOK 4168.52 34.00 12.11 -13.45 -201.73
Axsome Therapeutics, Inc. AXSM 2906.40 None 19.72 -32.31 None
Pacira Biosciences, Inc. PCRX 2427.60 435.00 6.51 -5780.00 -0.02
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
SAGE Therapeutics, Inc. SAGE 2231.84 9.00 2.62 -3.45 -413.06
Corcept Therapeutics, Inc. CORT 2013.00 335.00 4.62 18.97 31.64
Prestige Consumer Healthcare, Inc. PBH 1863.54 963.00 1.57 13.14 14.77
Revolution Medicines, Inc. RVMD 1798.91 48.00 4.67 -25.41 -146.29
Madrigal Pharmaceuticals, Inc. MDGL 1558.65 0.00 4.16 -15.26 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1548.02 440.00 -21.91 18.26 19.14
Innoviva, Inc. INVA 1544.71 285.00 3.66 7.99 66.41
Intercept Pharmaceuticals, Inc. ICPT 1440.96 272.00 -42.89 -4.20 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Supernus Pharmaceuticals, Inc. SUPN 1309.50 402.00 2.08 11.23 28.90
Theravance Biopharma, Inc. TBPH 1235.76 88.00 -8.67 -5.01 -280.80
Zogenix, Inc. ZGNX 1192.05 5.00 3.25 -2.80 -241.62
Revance Therapeutics, Inc. RVNC 1161.84 0.00 4.59 -6.23 41.82
Amphastar Pharmaceuticals, Inc. AMPH 996.66 327.00 2.49 19.56 15.90
Endo International Plc ENDP 784.32 3014.00 -1.07 -2.80 -9.09
BellRing Brands, Inc. BRBR 762.45 954.00 -0.41 5.78 13.98
Eagle Pharmaceuticals, Inc. EGRX 678.30 192.00 3.65 269.17 1.29
Assembly Biosciences, Inc. ASMB 667.58 16.00 2.99 -6.71 -601.75
Aerie Pharmaceuticals, Inc. AERI 638.73 79.00 5.07 -3.16 -252.92
Intersect ENT, Inc. XENT 577.76 102.00 5.45 -11.57 -48.61
Collegium Pharmaceutical, Inc. COLL 577.66 299.00 4.13 -44.71 -4.21
Catalyst Pharmaceuticals, Inc. CPRX 533.93 119.00 5.20 12.17 36.09
Anika Therapeutics, Inc. ANIK 494.90 125.00 1.71 17.85 22.73
BioDelivery Sciences International, Inc. BDSI 381.34 130.00 5.45 -51.81 -5.01
ANI Pharmaceuticals, Inc. ANIP 334.80 203.00 1.71 -214.62 -0.67
Albireo Pharma, Inc. ALBO 326.82 11.00 3.32 -4.28 -730.55
MEI Pharma, Inc. MEIP 275.56 5.00 4.74 -7.06 -539.48
Mallinckrodt Plc MNK 212.52 3037.00 0.11 -0.18 -39.56
Agile Therapeutics, Inc. AGRX 148.09 None 2.41 -7.17 None
Marinus Pharmaceuticals, Inc. MRNS 146.79 0.00 5.68 -2.18 None
Cerecor, Inc. CERC 118.22 7.00 7.56 -5.24 -429.22
Ampio Pharmaceuticals, Inc. AMPE 98.67 1.00 69.00 -5.31 None
Zynerba Pharmaceuticals, Inc. ZYNE 85.79 0.00 1.41 -2.39 -699.94
AcelRx Pharmaceuticals, Inc. ACRX 84.80 2.00 -1.56 -1.51 -644.25
Aclaris Therapeutics, Inc. ACRS 81.18 4.00 1.42 -0.59 None
Cassava Sciences, Inc. SAVA 76.66 41.00 4.03 -16.81 76.71
Adamas Pharmaceuticals, Inc. ADMS 75.32 57.00 -4.80 -0.81 -160.44
CTI BioPharma Corp. CTIC 71.98 3.00 3.21 -1.74 -111.83
Oramed Pharmaceuticals, Inc. ORMP 59.94 3.00 4.83 -4.69 -464.15
SCYNEXIS, Inc. SCYX 48.28 0.00 10.14 -1.25 -30.84
Cumberland Pharmaceuticals, Inc. CPIX 47.70 47.00 0.97 -10.60 -9.59
Natural Alternatives International, Inc. NAII 47.67 114.00 0.65 -12.61 -3.19
IsoRay, Inc. ISR 44.22 9.00 8.25 -13.20 -36.08
Lipocine, Inc. LPCN 40.20 0.00 9.57 -2.68 None
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 32.00 65.00 -2.46 -1.83 -26.74
PLx Pharma, Inc. PLXP 26.19 0.00 -2.51 -2.77 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
Evoke Pharma, Inc. EVOK 20.58 397.00 0.05 -7.15 -0.76
EyeGate Pharmaceuticals, Inc. EYEG 19.92 3.00 2.48 -1.68 -264.21
Regulus Therapeutics, Inc. RGLS 15.96 0.00 1.41 -0.75 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.15 8.00 0.64 -0.14 -798.18
Intec Pharma Ltd. NTEC 10.18 None 1.31 -0.24 None
Hepion Pharmaceuticals, Inc. HEPA 7.50 None 2.34 -0.63 None
Sonoma Pharmaceuticals, Inc. SNOA 6.44 19.00 1.02 -2.06 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
VIVUS, Inc. VVUS 5.83 73.00 -0.13 -0.20 -39.28
Tonix Pharmaceuticals Holding Corp. TNXP 4.48 None 1.12 -0.09 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Did Hedge Funds Make The Right Call On SAGE Therapeutics Inc (SAGE)

7h ago, source: YAHOO!

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will ...

9,721 Shares in SAGE Therapeutics Inc (NASDAQ:SAGE) Acquired by Squarepoint Ops LLC

6d ago, source: theenterpriseleader.com

Squarepoint Ops LLC bought a new position in shares of SAGE Therapeutics Inc (NASDAQ:SAGE) during the first quarter, ...

Brokerages Set SAGE Therapeutics Inc (NASDAQ:SAGE) PT at $83.12

2d ago, source: theenterpriseleader.com

SAGE Therapeutics Inc (NASDAQ:SAGE) has earned an average recommendation of “Buy” from the twenty-two brokerages that are ...

Essential Tremor Treatment Market Mergers & Acquisitions, Expansion, Concentration Rate Outlook (2020-2024)

21h ago, source: MarketWatch

Global “Essential Tremor Treatment Market “ report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Moreover, the ...

Government's SAGE group's role in coronavirus will be 'downgraded'

5d ago, source: Daily Mail

Scientists said they were concerned that the JBC would end up being even less transparent than SAGE is, giving the public no ...

2,500 elderly persons to benefit from SAGE program in Hoima

2d ago, source: independent.co.ug

At least 2,500 elderly persons have been registered to benefit from the Social Assistance Grant for Empowerment-SAGE program ...

SAGE Eldercare executive director steps down

6d ago, source: NJ.com

Angela Sullivan has informed the SAGE Board of Trustees of her decision to step down from her role as executive director on or about Aug. 30.



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.